Sulfadoxine- pyrimethamine+ amodiaquine dispersible
Access
-
Approved
SPAQ-CO™
Fosun Pharma
Paediatric formulation
Intermittent preventative treatment (TPP-1)
Therapeutic indication |
|
Dosing |
|
Efficacy |
|
Key features |
|
Challenges |
|
Status |
|
Next milestone | |
Project Director |
|